Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis

M. Lebwohl; R. B. Warren

doi:10.1111/jdv.17026

Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	3-4
Number of pages	2
Journal	Journal of the European Academy of Dermatology and Venereology
Volume	35
Issue number	S1
DOIs	https://doi.org/10.1111/jdv.17026
State	Published - Feb 2021

Access to Document

10.1111/jdv.17026

Cite this

@article{0a143c3c141748448d18a29c14f77c32,

title = "Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis",

author = "M. Lebwohl and Warren, {R. B.}",

note = "Funding Information: Development of this manuscript was funded by LEO Pharma. ML is an employee of Mount Sinai and receives research funds from: Abbvie, Amgen, Arcutis, Boehringer Ingelheim, Dermavant, Eli Lilly, Incyte, Janssen Research & Development, LLC, Ortho Dermatologics, Pfizer and UCB, Inc. and is a consultant for Aditum Bio, Allergan, Almirall, Arcutis Inc., Avotres Therapeutics, BirchBioMed Inc., BMD skincare, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant Sciences, Evelo, Facilitate International Dermatologic Education, Foundation for Research and Education in Dermatology, Inozyme Pharma, Kyowa Kirin, LEO Pharma, Meiji Seika Pharma, Menlo, Mitsubishi, Neuroderm, Pfizer, Promius/Dr. Reddy{\textquoteright}s Laboratories, Serono, Theravance and Verrica. RBW receives research grants from AbbVie Inc., Almirall, Amgen, Celgene, Janssen Pharmaceuticals, Eli Lilly and Company, LEO Pharma, Novartis, Pfizer and UCB. Dr Warren is a consultant for AbbVie Inc., Almirall, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Janssen Pharmaceuticals, LEO Pharma, Eli Lilly and Company, Novartis, Pfizer, Sanofi and UCB. Funding Information: ML is an employee of Mount Sinai and receives research funds from: Abbvie, Amgen, Arcutis, Boehringer Ingelheim, Dermavant, Eli Lilly, Incyte, Janssen Research & Development, LLC, Ortho Dermatologics, Pfizer and UCB, Inc. and is a consultant for Aditum Bio, Allergan, Almirall, Arcutis Inc., Avotres Therapeutics, BirchBioMed Inc., BMD skincare, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant Sciences, Evelo, Facilitate International Dermatologic Education, Foundation for Research and Education in Dermatology, Inozyme Pharma, Kyowa Kirin, LEO Pharma, Meiji Seika Pharma, Menlo, Mitsubishi, Neuroderm, Pfizer, Promius/Dr. Reddy{\textquoteright}s Laboratories, Serono, Theravance and Verrica. RBW receives research grants from AbbVie Inc., Almirall, Amgen, Celgene, Janssen Pharmaceuticals, Eli Lilly and Company, LEO Pharma, Novartis, Pfizer and UCB. Dr Warren is a consultant for AbbVie Inc., Almirall, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Janssen Pharmaceuticals, LEO Pharma, Eli Lilly and Company, Novartis, Pfizer, Sanofi and UCB. ",

year = "2021",

month = feb,

doi = "10.1111/jdv.17026",

language = "English",

volume = "35",

pages = "3--4",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "Wiley-Blackwell",

number = "S1",

}

TY - JOUR

T1 - Editorial

T2 - fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis

AU - Lebwohl, M.

AU - Warren, R. B.

N1 - Funding Information: Development of this manuscript was funded by LEO Pharma. ML is an employee of Mount Sinai and receives research funds from: Abbvie, Amgen, Arcutis, Boehringer Ingelheim, Dermavant, Eli Lilly, Incyte, Janssen Research & Development, LLC, Ortho Dermatologics, Pfizer and UCB, Inc. and is a consultant for Aditum Bio, Allergan, Almirall, Arcutis Inc., Avotres Therapeutics, BirchBioMed Inc., BMD skincare, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant Sciences, Evelo, Facilitate International Dermatologic Education, Foundation for Research and Education in Dermatology, Inozyme Pharma, Kyowa Kirin, LEO Pharma, Meiji Seika Pharma, Menlo, Mitsubishi, Neuroderm, Pfizer, Promius/Dr. Reddy’s Laboratories, Serono, Theravance and Verrica. RBW receives research grants from AbbVie Inc., Almirall, Amgen, Celgene, Janssen Pharmaceuticals, Eli Lilly and Company, LEO Pharma, Novartis, Pfizer and UCB. Dr Warren is a consultant for AbbVie Inc., Almirall, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Janssen Pharmaceuticals, LEO Pharma, Eli Lilly and Company, Novartis, Pfizer, Sanofi and UCB. Funding Information: ML is an employee of Mount Sinai and receives research funds from: Abbvie, Amgen, Arcutis, Boehringer Ingelheim, Dermavant, Eli Lilly, Incyte, Janssen Research & Development, LLC, Ortho Dermatologics, Pfizer and UCB, Inc. and is a consultant for Aditum Bio, Allergan, Almirall, Arcutis Inc., Avotres Therapeutics, BirchBioMed Inc., BMD skincare, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Corrona, Dermavant Sciences, Evelo, Facilitate International Dermatologic Education, Foundation for Research and Education in Dermatology, Inozyme Pharma, Kyowa Kirin, LEO Pharma, Meiji Seika Pharma, Menlo, Mitsubishi, Neuroderm, Pfizer, Promius/Dr. Reddy’s Laboratories, Serono, Theravance and Verrica. RBW receives research grants from AbbVie Inc., Almirall, Amgen, Celgene, Janssen Pharmaceuticals, Eli Lilly and Company, LEO Pharma, Novartis, Pfizer and UCB. Dr Warren is a consultant for AbbVie Inc., Almirall, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Janssen Pharmaceuticals, LEO Pharma, Eli Lilly and Company, Novartis, Pfizer, Sanofi and UCB.

PY - 2021/2

Y1 - 2021/2

UR - http://www.scopus.com/inward/record.url?scp=85101282982&partnerID=8YFLogxK

U2 - 10.1111/jdv.17026

DO - 10.1111/jdv.17026

M3 - Editorial

C2 - 33619781

AN - SCOPUS:85101282982

SN - 0926-9959

VL - 35

SP - 3

EP - 4

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - S1

ER -